GI & Endoscopy

Here are three gastroenterologists in the news this past week.

J. Calvin Coffey, PhD, of Ireland-based University of Limerick, argues that a structure in the digestive system should be classified as a new organ.

Joseph Binns, MD, is a gastroenterologist at Red Bank (N.J.) Gastroenterology.

The pancreatitis program at Methodist Dallas Medical Center earned a Gold Seal of Approval from The Joint Commission, Dallas/Fort Worth Healthcare Daily reports.

Lancaster Gastroenterology and RGAL Gastroenterology Specialists merged practices, becoming Regional GI, Lancaster Online reports.

Laval, Canada-based Valeant Pharmaceuticals' board of directors elected Richard DeSchutter director.

Researchers from Nashville, Tenn.-based Vanderbilt University created an endoscope that uses Raman spectroscopy, a chemical-fingerprinting technique, to detect inflammatory bowel disease in the colon.

A study in Journal of Clinical Gastroenterology investigated the effect of the specific carbohydrate diet on active inflammatory bowel disease, to determine whether diet is an effective therapeutic option.

Here are three updates on gastroenterology and endoscopy companies.

J. Scott Buckley is a gastroenterologist at Indianapolis' Indy Gastro and the medical director of the Franciscan Health endoscopy center, also in Indianapolis.